Impact of DuoTherm on Opioid Use and Low Back Pain
Addressing Opioid Use Disorder With an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing Pain Relief in Acute and Chronic Low Back Pain
Sponsor: MMJ Labs LLC
A NA clinical study on Low Back Pain and Opioid Use, this trial is completed. The trial is conducted by MMJ Labs LLC and has accumulated 12 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Feb 2025 — Sep 2025 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Nov 2024 — Feb 2025 [monthly]
Active Not Recruiting NA
-
Sep 2024 — Nov 2024 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
▶ Show 7 earlier versions
-
Mar 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Mar 2023 — Mar 2024 [monthly]
Recruiting NA
-
Nov 2022 — Mar 2023 [monthly]
Recruiting NA
-
Sep 2022 — Nov 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Apr 2021 — Sep 2022 [monthly]
Not Yet Recruiting NA
-
Jan 2021 — Apr 2021 [monthly]
Not Yet Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- MMJ Labs LLC
- National Institute on Drug Abuse (NIDA)
- Sport and Spine Rehab Clinical Research Foundation
For direct contact, visit the study record on ClinicalTrials.gov .